Global NSAIDs Drug Market Growth (Status and Outlook) 2025-2031

October 2025 | 102 pages | ID: G49ABECA86ABEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global NSAIDs Drug market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “NSAIDs Drug Industry Forecast” looks at past sales and reviews total world NSAIDs Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected NSAIDs Drug sales for 2025 through 2031. With NSAIDs Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSAIDs Drug industry.

This Insight Report provides a comprehensive analysis of the global NSAIDs Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NSAIDs Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NSAIDs Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSAIDs Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSAIDs Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of NSAIDs Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Ibuprofen
  • Naproxen
Segmentation by Application:
  • Hospitals
  • Clinics
  • Drugstores
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • GSK
  • Grunenthal
  • Bayer
  • Sanofi
  • Eli Lilly
  • AstraZeneca
  • Endo
  • Merck
  • Depomed
  • Yunnan Baiyao
  • Teva
  • J&J
  • Allergan
  • Purdue
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global NSAIDs Drug Market Size (2020-2031)
  2.1.2 NSAIDs Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for NSAIDs Drug by Country/Region (2020, 2024 & 2031)
2.2 NSAIDs Drug Segment by Type
  2.2.1 Ibuprofen
  2.2.2 Naproxen
2.3 NSAIDs Drug Market Size by Type
  2.3.1 NSAIDs Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global NSAIDs Drug Market Size Market Share by Type (2020-2025)
2.4 NSAIDs Drug Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Drugstores
2.5 NSAIDs Drug Market Size by Application
  2.5.1 NSAIDs Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global NSAIDs Drug Market Size Market Share by Application (2020-2025)

3 NSAIDS DRUG MARKET SIZE BY PLAYER

3.1 NSAIDs Drug Market Size Market Share by Player
  3.1.1 Global NSAIDs Drug Revenue by Player (2020-2025)
  3.1.2 Global NSAIDs Drug Revenue Market Share by Player (2020-2025)
3.2 Global NSAIDs Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NSAIDS DRUG BY REGION

4.1 NSAIDs Drug Market Size by Region (2020-2025)
4.2 Global NSAIDs Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas NSAIDs Drug Market Size Growth (2020-2025)
4.4 APAC NSAIDs Drug Market Size Growth (2020-2025)
4.5 Europe NSAIDs Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa NSAIDs Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas NSAIDs Drug Market Size by Country (2020-2025)
5.2 Americas NSAIDs Drug Market Size by Type (2020-2025)
5.3 Americas NSAIDs Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC NSAIDs Drug Market Size by Region (2020-2025)
6.2 APAC NSAIDs Drug Market Size by Type (2020-2025)
6.3 APAC NSAIDs Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe NSAIDs Drug Market Size by Country (2020-2025)
7.2 Europe NSAIDs Drug Market Size by Type (2020-2025)
7.3 Europe NSAIDs Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa NSAIDs Drug by Region (2020-2025)
8.2 Middle East & Africa NSAIDs Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa NSAIDs Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NSAIDS DRUG MARKET FORECAST

10.1 Global NSAIDs Drug Forecast by Region (2026-2031)
  10.1.1 Global NSAIDs Drug Forecast by Region (2026-2031)
  10.1.2 Americas NSAIDs Drug Forecast
  10.1.3 APAC NSAIDs Drug Forecast
  10.1.4 Europe NSAIDs Drug Forecast
  10.1.5 Middle East & Africa NSAIDs Drug Forecast
10.2 Americas NSAIDs Drug Forecast by Country (2026-2031)
  10.2.1 United States Market NSAIDs Drug Forecast
  10.2.2 Canada Market NSAIDs Drug Forecast
  10.2.3 Mexico Market NSAIDs Drug Forecast
  10.2.4 Brazil Market NSAIDs Drug Forecast
10.3 APAC NSAIDs Drug Forecast by Region (2026-2031)
  10.3.1 China NSAIDs Drug Market Forecast
  10.3.2 Japan Market NSAIDs Drug Forecast
  10.3.3 Korea Market NSAIDs Drug Forecast
  10.3.4 Southeast Asia Market NSAIDs Drug Forecast
  10.3.5 India Market NSAIDs Drug Forecast
  10.3.6 Australia Market NSAIDs Drug Forecast
10.4 Europe NSAIDs Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market NSAIDs Drug Forecast
  10.4.2 France Market NSAIDs Drug Forecast
  10.4.3 UK Market NSAIDs Drug Forecast
  10.4.4 Italy Market NSAIDs Drug Forecast
  10.4.5 Russia Market NSAIDs Drug Forecast
10.5 Middle East & Africa NSAIDs Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market NSAIDs Drug Forecast
  10.5.2 South Africa Market NSAIDs Drug Forecast
  10.5.3 Israel Market NSAIDs Drug Forecast
  10.5.4 Turkey Market NSAIDs Drug Forecast
10.6 Global NSAIDs Drug Forecast by Type (2026-2031)
10.7 Global NSAIDs Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market NSAIDs Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer NSAIDs Drug Product Offered
  11.1.3 Pfizer NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK NSAIDs Drug Product Offered
  11.2.3 GSK NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Grunenthal
  11.3.1 Grunenthal Company Information
  11.3.2 Grunenthal NSAIDs Drug Product Offered
  11.3.3 Grunenthal NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Grunenthal Main Business Overview
  11.3.5 Grunenthal Latest Developments
11.4 Bayer
  11.4.1 Bayer Company Information
  11.4.2 Bayer NSAIDs Drug Product Offered
  11.4.3 Bayer NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bayer Main Business Overview
  11.4.5 Bayer Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi NSAIDs Drug Product Offered
  11.5.3 Sanofi NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Eli Lilly
  11.6.1 Eli Lilly Company Information
  11.6.2 Eli Lilly NSAIDs Drug Product Offered
  11.6.3 Eli Lilly NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Eli Lilly Main Business Overview
  11.6.5 Eli Lilly Latest Developments
11.7 AstraZeneca
  11.7.1 AstraZeneca Company Information
  11.7.2 AstraZeneca NSAIDs Drug Product Offered
  11.7.3 AstraZeneca NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 AstraZeneca Main Business Overview
  11.7.5 AstraZeneca Latest Developments
11.8 Endo
  11.8.1 Endo Company Information
  11.8.2 Endo NSAIDs Drug Product Offered
  11.8.3 Endo NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Endo Main Business Overview
  11.8.5 Endo Latest Developments
11.9 Merck
  11.9.1 Merck Company Information
  11.9.2 Merck NSAIDs Drug Product Offered
  11.9.3 Merck NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Merck Main Business Overview
  11.9.5 Merck Latest Developments
11.10 Depomed
  11.10.1 Depomed Company Information
  11.10.2 Depomed NSAIDs Drug Product Offered
  11.10.3 Depomed NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Depomed Main Business Overview
  11.10.5 Depomed Latest Developments
11.11 Yunnan Baiyao
  11.11.1 Yunnan Baiyao Company Information
  11.11.2 Yunnan Baiyao NSAIDs Drug Product Offered
  11.11.3 Yunnan Baiyao NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Yunnan Baiyao Main Business Overview
  11.11.5 Yunnan Baiyao Latest Developments
11.12 Teva
  11.12.1 Teva Company Information
  11.12.2 Teva NSAIDs Drug Product Offered
  11.12.3 Teva NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Teva Main Business Overview
  11.12.5 Teva Latest Developments
11.13 J&J
  11.13.1 J&J Company Information
  11.13.2 J&J NSAIDs Drug Product Offered
  11.13.3 J&J NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 J&J Main Business Overview
  11.13.5 J&J Latest Developments
11.14 Allergan
  11.14.1 Allergan Company Information
  11.14.2 Allergan NSAIDs Drug Product Offered
  11.14.3 Allergan NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Allergan Main Business Overview
  11.14.5 Allergan Latest Developments
11.15 Purdue
  11.15.1 Purdue Company Information
  11.15.2 Purdue NSAIDs Drug Product Offered
  11.15.3 Purdue NSAIDs Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Purdue Main Business Overview
  11.15.5 Purdue Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. NSAIDs Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. NSAIDs Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ibuprofen
Table 4. Major Players of Naproxen
Table 5. NSAIDs Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global NSAIDs Drug Market Size by Type (2020-2025) & ($ millions)
Table 7. Global NSAIDs Drug Market Size Market Share by Type (2020-2025)
Table 8. NSAIDs Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global NSAIDs Drug Market Size by Application (2020-2025) & ($ millions)
Table 10. Global NSAIDs Drug Market Size Market Share by Application (2020-2025)
Table 11. Global NSAIDs Drug Revenue by Player (2020-2025) & ($ millions)
Table 12. Global NSAIDs Drug Revenue Market Share by Player (2020-2025)
Table 13. NSAIDs Drug Key Players Head office and Products Offered
Table 14. NSAIDs Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global NSAIDs Drug Market Size by Region (2020-2025) & ($ millions)
Table 18. Global NSAIDs Drug Market Size Market Share by Region (2020-2025)
Table 19. Global NSAIDs Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global NSAIDs Drug Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas NSAIDs Drug Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas NSAIDs Drug Market Size Market Share by Country (2020-2025)
Table 23. Americas NSAIDs Drug Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas NSAIDs Drug Market Size Market Share by Type (2020-2025)
Table 25. Americas NSAIDs Drug Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas NSAIDs Drug Market Size Market Share by Application (2020-2025)
Table 27. APAC NSAIDs Drug Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC NSAIDs Drug Market Size Market Share by Region (2020-2025)
Table 29. APAC NSAIDs Drug Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC NSAIDs Drug Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe NSAIDs Drug Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe NSAIDs Drug Market Size Market Share by Country (2020-2025)
Table 33. Europe NSAIDs Drug Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe NSAIDs Drug Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa NSAIDs Drug Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa NSAIDs Drug Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa NSAIDs Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of NSAIDs Drug
Table 39. Key Market Challenges & Risks of NSAIDs Drug
Table 40. Key Industry Trends of NSAIDs Drug
Table 41. Global NSAIDs Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global NSAIDs Drug Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global NSAIDs Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global NSAIDs Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 46. Pfizer NSAIDs Drug Product Offered
Table 47. Pfizer NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. GSK Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 51. GSK NSAIDs Drug Product Offered
Table 52. GSK NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GSK Main Business
Table 54. GSK Latest Developments
Table 55. Grunenthal Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 56. Grunenthal NSAIDs Drug Product Offered
Table 57. Grunenthal NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Grunenthal Main Business
Table 59. Grunenthal Latest Developments
Table 60. Bayer Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 61. Bayer NSAIDs Drug Product Offered
Table 62. Bayer NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bayer Main Business
Table 64. Bayer Latest Developments
Table 65. Sanofi Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 66. Sanofi NSAIDs Drug Product Offered
Table 67. Sanofi NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments
Table 70. Eli Lilly Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 71. Eli Lilly NSAIDs Drug Product Offered
Table 72. Eli Lilly NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Latest Developments
Table 75. AstraZeneca Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 76. AstraZeneca NSAIDs Drug Product Offered
Table 77. AstraZeneca NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Latest Developments
Table 80. Endo Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 81. Endo NSAIDs Drug Product Offered
Table 82. Endo NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Endo Main Business
Table 84. Endo Latest Developments
Table 85. Merck Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 86. Merck NSAIDs Drug Product Offered
Table 87. Merck NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Depomed Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 91. Depomed NSAIDs Drug Product Offered
Table 92. Depomed NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Depomed Main Business
Table 94. Depomed Latest Developments
Table 95. Yunnan Baiyao Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 96. Yunnan Baiyao NSAIDs Drug Product Offered
Table 97. Yunnan Baiyao NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Yunnan Baiyao Main Business
Table 99. Yunnan Baiyao Latest Developments
Table 100. Teva Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 101. Teva NSAIDs Drug Product Offered
Table 102. Teva NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Teva Main Business
Table 104. Teva Latest Developments
Table 105. J&J Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 106. J&J NSAIDs Drug Product Offered
Table 107. J&J NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. J&J Main Business
Table 109. J&J Latest Developments
Table 110. Allergan Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 111. Allergan NSAIDs Drug Product Offered
Table 112. Allergan NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Allergan Main Business
Table 114. Allergan Latest Developments
Table 115. Purdue Details, Company Type, NSAIDs Drug Area Served and Its Competitors
Table 116. Purdue NSAIDs Drug Product Offered
Table 117. Purdue NSAIDs Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Purdue Main Business
Table 119. Purdue Latest Developments

LIST OF FIGURES

Figure 1. NSAIDs Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NSAIDs Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. NSAIDs Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. NSAIDs Drug Sales Market Share by Country/Region (2024)
Figure 8. NSAIDs Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global NSAIDs Drug Market Size Market Share by Type in 2024
Figure 10. NSAIDs Drug in Hospitals
Figure 11. Global NSAIDs Drug Market: Hospitals (2020-2025) & ($ millions)
Figure 12. NSAIDs Drug in Clinics
Figure 13. Global NSAIDs Drug Market: Clinics (2020-2025) & ($ millions)
Figure 14. NSAIDs Drug in Drugstores
Figure 15. Global NSAIDs Drug Market: Drugstores (2020-2025) & ($ millions)
Figure 16. Global NSAIDs Drug Market Size Market Share by Application in 2024
Figure 17. Global NSAIDs Drug Revenue Market Share by Player in 2024
Figure 18. Global NSAIDs Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas NSAIDs Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC NSAIDs Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe NSAIDs Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa NSAIDs Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas NSAIDs Drug Value Market Share by Country in 2024
Figure 24. United States NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC NSAIDs Drug Market Size Market Share by Region in 2024
Figure 29. APAC NSAIDs Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC NSAIDs Drug Market Size Market Share by Application (2020-2025)
Figure 31. China NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe NSAIDs Drug Market Size Market Share by Country in 2024
Figure 38. Europe NSAIDs Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe NSAIDs Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa NSAIDs Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa NSAIDs Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa NSAIDs Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries NSAIDs Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 57. United States NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 61. China NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 65. India NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 68. France NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 69. UK NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey NSAIDs Drug Market Size 2026-2031 ($ millions)
Figure 76. Global NSAIDs Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global NSAIDs Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries NSAIDs Drug Market Size 2026-2031 ($ millions)


More Publications